Inhibitory Effect of r-Hirudin Variant III on Streptozotocin-Induced Diabetic Cataracts in Rats

Table 2

The body weight and lens opacity of cataractous rats after four weeks treatment with rHV3 eye drops (𝑥±𝑠).

Group	𝑛	Body weight (g)	Lens opacity
A	16	360.69±31.63^∗∗	0.19±0.40^∗∗##
B	13	170.85±28.65	3.69±0.63
C	13	170.15±26.70	2.00±0.82^∗∗##
D	14	164.93±14.58	1.86±0.53^∗∗##
E	15	166.73±32.30	1.73±0.46^∗∗##
F	12	171.25±29.89	3.00±0.85

 ^∗∗𝑃<0.01 versus group B (model, treated with eye drops vehicle).
 ^##𝑃<0.01 versus group F (pirenoxine treated).